Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology

Giulia Marvaso, Barbara Alicja Jereczek-Fossa, Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Nicolaus Andratschke, Ehsan Balagamwala, Jens Bedke, Oliver Blanck, Umberto Capitanio, Rohann Correa, Gert de Meerleer, Ciro Franzese, Aurora Gaeta, Sara Gandini, Cristina Garibaldi, Peter Gerszten, Silke Gillessen, William Grubb, Matthias Guckenberger, Raquibul Hannan, Pavan Jhaveri, Mirjana Josipovic, Linda Kerkmeijer, Eric Lehrer, Magnus Lindskog, Alexander Louie, Quynh-Nhu Nguyen, Piet Ost, David Palma, Giuseppe Procopio, Maddalena Rossi, Michael Staehler, Alison Tree, Yat Man Tsang, Nicholas van As, Nicholas Zaorsky, Thomas Zilli, David Pasquier, Shankar Siva

Open source

DOI: 10.1016/s1470-2045(24)00023-8
Published: 2024-05
Container: Lancet Oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00023-8,
  title = {Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology},
  author = {Giulia Marvaso and Barbara Alicja Jereczek-Fossa and Mattia Zaffaroni and Maria Giulia Vincini and Giulia Corrao and Nicolaus Andratschke and Ehsan Balagamwala and Jens Bedke and Oliver Blanck and Umberto Capitanio and Rohann Correa and Gert de Meerleer and Ciro Franzese and Aurora Gaeta and Sara Gandini and Cristina Garibaldi and Peter Gerszten and Silke Gillessen and William Grubb and Matthias Guckenberger and Raquibul Hannan and Pavan Jhaveri and Mirjana Josipovic and Linda Kerkmeijer and Eric Lehrer and Magnus Lindskog and Alexander Louie and Quynh-Nhu Nguyen and Piet Ost and David Palma and Giuseppe Procopio and Maddalena Rossi and Michael Staehler and Alison Tree and Yat Man Tsang and Nicholas van As and Nicholas Zaorsky and Thomas Zilli and David Pasquier and Shankar Siva},
  year = {2024},
  journal = {Lancet Oncology},
  doi = {10.1016/s1470-2045(24)00023-8},
  url = {https://doi.org/10.1016/s1470-2045(24)00023-8}
}

RIS

TY  - JOUR
TI  - Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
AU  - Giulia Marvaso
AU  - Barbara Alicja Jereczek-Fossa
AU  - Mattia Zaffaroni
AU  - Maria Giulia Vincini
AU  - Giulia Corrao
AU  - Nicolaus Andratschke
AU  - Ehsan Balagamwala
AU  - Jens Bedke
AU  - Oliver Blanck
AU  - Umberto Capitanio
AU  - Rohann Correa
AU  - Gert de Meerleer
AU  - Ciro Franzese
AU  - Aurora Gaeta
AU  - Sara Gandini
AU  - Cristina Garibaldi
AU  - Peter Gerszten
AU  - Silke Gillessen
AU  - William Grubb
AU  - Matthias Guckenberger
AU  - Raquibul Hannan
AU  - Pavan Jhaveri
AU  - Mirjana Josipovic
AU  - Linda Kerkmeijer
AU  - Eric Lehrer
AU  - Magnus Lindskog
AU  - Alexander Louie
AU  - Quynh-Nhu Nguyen
AU  - Piet Ost
AU  - David Palma
AU  - Giuseppe Procopio
AU  - Maddalena Rossi
AU  - Michael Staehler
AU  - Alison Tree
AU  - Yat Man Tsang
AU  - Nicholas van As
AU  - Nicholas Zaorsky
AU  - Thomas Zilli
AU  - David Pasquier
AU  - Shankar Siva
PY  - 2024
JO  - Lancet Oncology
DO  - 10.1016/s1470-2045(24)00023-8
UR  - https://doi.org/10.1016/s1470-2045(24)00023-8
ER  -

APA

Marvaso, G., Jereczek-Fossa, B. A., Zaffaroni, M., Vincini, M. G., Corrao, G., Andratschke, N., Balagamwala, E., Bedke, J., Blanck, O., Capitanio, U., Correa, R., Meerleer, G. D., Franzese, C., Gaeta, A., Gandini, S., Garibaldi, C., Gerszten, P., Gillessen, S., Grubb, W., Guckenberger, M., Hannan, R., Jhaveri, P., Josipovic, M., Kerkmeijer, L., Lehrer, E., Lindskog, M., Louie, A., Nguyen, Q., Ost, P., Palma, D., Procopio, G., Rossi, M., Staehler, M., Tree, A., Tsang, Y. M., As, N. V., Zaorsky, N., Zilli, T., Pasquier, D., & Siva, S. (2024). Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology. Lancet Oncology. https://doi.org/10.1016/s1470-2045(24)00023-8

Source records

hal · retrieved 2026-09-27T11:26:21.238Z